These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26244663)

  • 41. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.
    Choi JH; Banks AS; Estall JL; Kajimura S; Boström P; Laznik D; Ruas JL; Chalmers MJ; Kamenecka TM; Blüher M; Griffin PR; Spiegelman BM
    Nature; 2010 Jul; 466(7305):451-6. PubMed ID: 20651683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TLX activates MASH1 for induction of neuronal lineage commitment of adult hippocampal neuroprogenitors.
    Elmi M; Matsumoto Y; Zeng ZJ; Lakshminarasimhan P; Yang W; Uemura A; Nishikawa S; Moshiri A; Tajima N; Agren H; Funa K
    Mol Cell Neurosci; 2010 Oct; 45(2):121-31. PubMed ID: 20599619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.
    Holbeck S; Chang J; Best AM; Bookout AL; Mangelsdorf DJ; Martinez ED
    Mol Endocrinol; 2010 Jun; 24(6):1287-96. PubMed ID: 20375240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression profiling of nuclear receptors in human and mouse embryonic stem cells.
    Xie CQ; Jeong Y; Fu M; Bookout AL; Garcia-Barrio MT; Sun T; Kim BH; Xie Y; Root S; Zhang J; Xu RH; Chen YE; Mangelsdorf DJ
    Mol Endocrinol; 2009 May; 23(5):724-33. PubMed ID: 19196830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The neoplastic potentialities of mouse embryo tissues; lung adenomas in baby mice as result of prenatal exposure to urethane.
    SMITH WE; ROUS P
    J Exp Med; 1948 Nov; 88(5):529-54. PubMed ID: 18892428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation.
    Wang T; Alavian MR; Goel HL; Languino LR; Fitzgerald TJ
    Prostate; 2008 Dec; 68(16):1734-42. PubMed ID: 18729104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional control of energy homeostasis by the estrogen-related receptors.
    Giguère V
    Endocr Rev; 2008 Oct; 29(6):677-96. PubMed ID: 18664618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.
    Bren-Mattison Y; Meyer AM; Van Putten V; Li H; Kuhn K; Stearman R; Weiser-Evans M; Winn RA; Heasley LE; Nemenoff RA
    Mol Pharmacol; 2008 Mar; 73(3):709-17. PubMed ID: 18055759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergy between PPARgamma ligands and platinum-based drugs in cancer.
    Girnun GD; Naseri E; Vafai SB; Qu L; Szwaya JD; Bronson R; Alberta JA; Spiegelman BM
    Cancer Cell; 2007 May; 11(5):395-406. PubMed ID: 17482130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.
    Florez JC; Jablonski KA; Sun MW; Bayley N; Kahn SE; Shamoon H; Hamman RF; Knowler WC; Nathan DM; Altshuler D;
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1502-9. PubMed ID: 17213274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemoprevention of breast cancer with selective oestrogen-receptor modulators.
    Jordan VC
    Nat Rev Cancer; 2007 Jan; 7(1):46-53. PubMed ID: 17186017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease.
    Spears M; McSharry C; Thomson NC
    Clin Exp Allergy; 2006 Dec; 36(12):1494-504. PubMed ID: 17177672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.
    Bookout AL; Jeong Y; Downes M; Yu RT; Evans RM; Mangelsdorf DJ
    Cell; 2006 Aug; 126(4):789-99. PubMed ID: 16923397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
    Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
    Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.
    Pascual G; Fong AL; Ogawa S; Gamliel A; Li AC; Perissi V; Rose DW; Willson TM; Rosenfeld MG; Glass CK
    Nature; 2005 Sep; 437(7059):759-63. PubMed ID: 16127449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Nuclear Receptor Atlas: macrophage activation.
    Barish GD; Downes M; Alaynick WA; Yu RT; Ocampo CB; Bookout AL; Mangelsdorf DJ; Evans RM
    Mol Endocrinol; 2005 Oct; 19(10):2466-77. PubMed ID: 16051664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Nuclear Receptor Atlas: 3T3-L1 adipogenesis.
    Fu M; Sun T; Bookout AL; Downes M; Yu RT; Evans RM; Mangelsdorf DJ
    Mol Endocrinol; 2005 Oct; 19(10):2437-50. PubMed ID: 16051663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins.
    Ramirez RD; Sheridan S; Girard L; Sato M; Kim Y; Pollack J; Peyton M; Zou Y; Kurie JM; Dimaio JM; Milchgrub S; Smith AL; Souza RF; Gilbey L; Zhang X; Gandia K; Vaughan MB; Wright WE; Gazdar AF; Shay JW; Minna JD
    Cancer Res; 2004 Dec; 64(24):9027-34. PubMed ID: 15604268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Androgen deprivation therapy for prostate cancer: current status and future prospects.
    Miyamoto H; Messing EM; Chang C
    Prostate; 2004 Dec; 61(4):332-53. PubMed ID: 15389811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.